TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Tilray Inc (TLRY)

Healthcare Drug Manufacturers - Specialty & Generic
4.60 $
+2.2% vs. previous close
Closing price · As of: 3. Aug 2026

Tilray Inc (TLRY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,328 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet TLRY
Tick rows to compare them in a chart (up to 4) Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
5,963 5,864 5,718 5,907 5,749 5,863 4,916 2,904 2,861 2,932 2,075 2,328
1,123 869 857 923 979 989 991 945 963 1,019 719 792
243 196 199 311 277 265 289 304 364 345 205 226
632 354 307 355 378 353 359 352 364 407 220 231
111 123 122 139 140 158 149 167 147 152 118 189
314 342 331 343 357 372 380 372 388 396 292 301
2,722 2,721 2,728 2,737 2,711 2,798 1,877 1,032 1,033 1,051 752 752
1,311 1,291 1,262 1,247 1,226 1,212 1,224 29 35 32 23 43
1,355 1,269 1,181 1,216 1,050 1,032 1,013 860 772 771 549 733
728 535 447 408 396 390 379 385 368 362 258 358
382 226 158 53 54 56 44 40 44 46 34 40
107 120 122 144 137 139 143 147 152 160 115 318
273 293 292 288 288 272 253 235 228 225 223 200
4,577 4,561 4,559 4,691 4,692 4,858 3,943 2,074 2,116 2,207 1,557 1,614
-3,369 -3,434 -3,568 -3,625 -3,642 -3,895 -5,163 -6,651 -6,659 -6,835 -4,919 -4,969
69 73 75 79 88 86 91 98 106 110 113 112

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?